Jeffrey S. Hackman - Chief Executive Officer, Director at FENNEC PHARMACEUTICALS INC.

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
FENC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jeffrey S. Hackman since 10 Sep 2025

Reported holdings for Jeffrey S. Hackman in FENNEC PHARMACEUTICALS INC.

Form 4 holding Chief Executive Officer, Director

FENNEC PHARMACEUTICALS INC.

Security class
Stock Options
Shares / value
725,000
Estimated value
$1,412,250
Report date
31 Mar 2026
Price
$2.69
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Executive Officer, Director

FENNEC PHARMACEUTICALS INC.

Security class
Restricted Share Unit
Shares / value
475,000
Estimated value
Report date
28 Mar 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Transaction history for Jeffrey S. Hackman in FENNEC PHARMACEUTICALS INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .